Xiaolong Wang

Title: Xiaolong Wang: Innovator in Nanobody Technology

Introduction

Xiaolong Wang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of nanobody technology, particularly in the context of viral detection and analysis. With a total of 6 patents, his work has broad implications for public health and disease prevention.

Latest Patents

Wang's latest patents include a nanobody targeting the influenza A virus nucleoprotein and a nucleic acid encoding this nanobody. This innovation involves the construction of a nanobody phage library and phage screening technology to obtain a nanobody that can specifically bind to the influenza A virus nucleoprotein. This nanobody has potential applications in the early warning of influenza outbreaks and environmental detection of the virus. Additionally, he has developed a preparation method for a single-chain antibody fragment targeting the SARS-CoV-2 nucleocapsid protein. This fragment exhibits high affinity and specificity, making it suitable for various immunoassay platforms related to SARS-CoV-2 detection.

Career Highlights

Xiaolong Wang has worked with notable institutions such as Nanjing University and DePuy Synthes Products, Inc. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field of biotechnology.

Collaborations

Wang has collaborated with esteemed colleagues, including Yi Luo and Shixiang Yang. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Xiaolong Wang's innovative work in nanobody technology positions him as a key figure in the fight against viral infections. His patents and research have the potential to significantly enhance detection methods and public health responses.